CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 14,310
+350 (2.51%)
At close: Oct 1, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 184.67 billion as of October 1, 2026. Its market cap has decreased by -18.56% in one year.
Market Cap
184.67B
Enterprise Value
147.36B
Revenue
2.15B
Ranking
n/a
PE Ratio
24.22
Stock Price
14,310.00
ChartMarket Cap Chart
Since October 16, 2024, CellBion's market cap has decreased from 263.06B to 184.67B, a decrease of -29.80%. That is a compound annual growth rate of -16.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 184.67B | -39.02% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 333.62B |
| HEM Pharma | 238.26B |
| DAE HWA Pharmaceutical | 213.52B |
| NOVAREX | 177.70B |
| GC WellBeing | 170.40B |
| Vivozon Pharmaceutical | 169.96B |
| Cosmax Nbt | 153.34B |
| Kyung Dong Pharmaceutical | 147.09B |